Atara Biotherapeutics Inc (ATRA)
0.6998
-0.01
(-2.08%)
USD |
NASDAQ |
Apr 25, 16:00
0.6974
0.00 (0.00%)
Pre-Market: 09:05
Atara Biotherapeutics Accounts Payable (Quarterly): 3.684M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.684M |
September 30, 2023 | 6.511M |
June 30, 2023 | 4.138M |
March 31, 2023 | 5.068M |
December 31, 2022 | 6.871M |
September 30, 2022 | 11.30M |
June 30, 2022 | 12.80M |
March 31, 2022 | 11.94M |
December 31, 2021 | 17.37M |
September 30, 2021 | 16.54M |
June 30, 2021 | 12.30M |
March 31, 2021 | 17.36M |
December 31, 2020 | 7.118M |
September 30, 2020 | 5.19M |
June 30, 2020 | 5.106M |
March 31, 2020 | 8.079M |
December 31, 2019 | 7.963M |
September 30, 2019 | 5.155M |
June 30, 2019 | 6.42M |
March 31, 2019 | 6.168M |
December 31, 2018 | 3.719M |
Date | Value |
---|---|
September 30, 2018 | 6.193M |
June 30, 2018 | 6.545M |
March 31, 2018 | 6.098M |
December 31, 2017 | 14.71M |
September 30, 2017 | 5.539M |
June 30, 2017 | 5.243M |
March 31, 2017 | 2.204M |
December 31, 2016 | 2.778M |
September 30, 2016 | 4.463M |
June 30, 2016 | 3.235M |
March 31, 2016 | 1.896M |
December 31, 2015 | 1.445M |
September 30, 2015 | 1.853M |
June 30, 2015 | 1.703M |
March 31, 2015 | 0.794M |
December 31, 2014 | 0.44M |
September 30, 2014 | 0.569M |
June 30, 2014 | 0.577M |
March 31, 2014 | 1.402M |
December 31, 2013 | 0.606M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
3.684M
Minimum
Dec 2023
17.37M
Maximum
Dec 2021
8.995M
Average
7.118M
Median
Dec 2020
Accounts Payable (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 1.13M |
Palatin Technologies Inc | 1.594M |
iBio Inc | 1.859M |
Theriva Biologics Inc | 0.77M |
Oragenics Inc | 1.245M |